0.83 USD
↘ 0.01 (1.16%)PRE MARKET (AS OF 04:01 AM EST)
Allogene Therapeutics, Inc. Common Stock (ALLO) trades at $0.83 per share. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On valuation, ALLO trades roughly in line with sector averages — neither particularly cheap nor expensive.
Technical & fundamental data as of Nov 13, 2026.